Inventor · disambiguated record
Martin Haberey
Also filed as: HABEREY MARTIN
39 granted patents·14 pending applications·604 citations·filing 1982–2011
98Inventor score
Top patents by PatentIndex Score
53 records- 0195US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0294US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 0389US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 0489US6818661B2Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 16, 2004·21 cites·5 claims
- 0589US5446035A20-methyl-substituted vitamin D derivativesSCHERING AG·Filed 1994·Granted Aug 29, 1995·79 cites·7 claims
- 0685US5411949A23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agentsSCHERING AG·Filed 1992·Granted May 2, 1995·55 cites·5 claims
- 0784US7148357B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesSCHERING AG·Filed 2003·Granted Dec 12, 2006·15 cites·3 claims
- 0883US7202260B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridonesSCHERING AG·Filed 2004·Granted Apr 10, 2007·11 cites·14 claims
- 0983US6376480B1Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agentsSCHERING AG·Filed 2000·Granted Apr 23, 2002·18 cites·17 claims
- 1081US7615565B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 10, 2009·3 cites·9 claims
- 1181US7012081B2Anthranyl amides and their use as medicamentsSCHERING AG·Filed 2001·Granted Mar 14, 2006·14 cites·12 claims
- 1278US7429592B2Cyanoanthranilamide derivatives and the use thereof as medicamentsSCHERING AG·Filed 2002·Granted Sep 30, 2008·12 cites·10 claims
- 1377US6603031B1Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agentsSCHERING AG·Filed 2000·Granted Aug 5, 2003·10 cites·5 claims
- 1477US5583125A25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 1993·Granted Dec 10, 1996·37 cites·26 claims
- 1576US7081468B2Ortho-substituted anthranilic acid amides and their use as medicamentsSCHERING AG·Filed 2001·Granted Jul 25, 2006·8 cites·4 claims
- 1676US5585368A20-position modified pharmaceutically active vitamin D series compoundsSCHERING AG·Filed 1993·Granted Dec 17, 1996·29 cites·15 claims
- 1774US7459470B2N-oxide anthranylamide derivatives and their use as medicamentsSCHERING AG·Filed 2002·Granted Dec 2, 2008·8 cites·10 claims
- 1873US7906533B2Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 15, 2011·1 cites·22 claims
- 1972US6613920B1Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agentsSCHERING AG·Filed 2000·Granted Sep 2, 2003·4 cites·26 claims
- 2071US7211680B2Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicamentsSCHERING AG·Filed 2003·Granted May 1, 2007·4 cites·18 claims
- 2171US6600058B1Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicamentsSCHERING AKTIENGELLSCHAFT·Filed 2000·Granted Jul 29, 2003·4 cites·27 claims
- 2271US5663157A22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agentsSCHERING AG·Filed 1993·Granted Sep 2, 1997·25 cites·16 claims
- 2371US5013758ANovel carbacyclins, processes for their preparation and their use as medicinal agentsSCHERING AG·Filed 1989·Granted May 7, 1991·15 cites·20 claims
- 2469US7115758B2Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agentsSCHERING AG·Filed 2002·Granted Oct 3, 2006·4 cites·31 claims
- 2568US6531459B1Vitamin D derivatives with phosphorus atoms in the side chainsSCHERING AG·Filed 1998·Granted Mar 11, 2003·28 cites·16 claims
- 2666US6372731B1Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicamentsSCHERING AG·Filed 1996·Granted Apr 16, 2002·21 cites·6 claims
- 2763US5700791AVitamin D derivatives modified in the 20-position and pharmaceutical compositions thereofSCHERING AG·Filed 1996·Granted Dec 23, 1997·17 cites·10 claims
- 2863US4532236ACertain prostacyclins and their blood-pressure-lowering and thrombocyte-aggregation-inhibiting compositions and methodsSCHERING AG·Filed 1982·Granted Jul 30, 1985·5 cites·26 claims
- 2962US6747046B2Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agentsSCHERING AG·Filed 2002·Granted Jun 8, 2004·1 cites·9 claims
- 3057US2006074112A1N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitorsALTMANN KARL-HEINZ·Filed 2005·Application pending·0 cites
- 3157US2006287339A1Aza- and polyazanthranyl amides and their use as medicamentsSEIDELMANN DIETER·Filed 2006·Application pending·0 cites
- 3256US2007135489A1Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridonesHUTH ANDREAS·Filed 2007·Application pending·0 cites
- 3355US7902229B2Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 8, 2011·0 cites·17 claims
- 3453US7479491B2Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitorsNOVARTIS AG·Filed 2004·Granted Jan 20, 2009·0 cites·3 claims
- 3552US6642218B2Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicamentsSCHERING AG·Filed 1997·Granted Nov 4, 2003·7 cites·28 claims
- 3652US2004039019A1Selected anthranilaminde pyridinamides and their use as pharmaceutical agentsSCHERING AG·Filed 2003·Application pending·0 cites
- 3752US2004147449A1Combinations and compositions which interfere with VEGF/ VEGF and angiopoietin/ Tie receptor function and their use (II)Filed 2004·Application pending·0 cites
- 3851US2004186156A1Substituted N-(1,4,5,6,-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agentsFiled 2004·Application pending·0 cites
- 3950US2011071165A1Aza- and polyazanthranyl amides and their use as medicamentsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 4050US2003018194A1New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agentsFiled 2002·Application pending·0 cites
- 4149US2004224968A1Aza-and polyazanthranyl amides and their use as medicamentsFiled 2001·Application pending·0 cites
- 4247US4868166A2,2:6,6-diethylen-3-oxo-17alpha-pregn-4-ene-21,17alpha-carbolactones, process for their production & pharmaceutical preparations containing themSCHERING AG·Filed 1987·Granted Sep 19, 1989·5 cites·7 claims
- 4346US2003055006A1Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their useSCHERING AG·Filed 2001·Application pending·0 cites
- 4445US7517894B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinesBAYER SCHERING PHARMA AG·Filed 2004·Granted Apr 14, 2009·0 cites·11 claims
- 4544US7572794B2Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Aug 11, 2009·0 cites·40 claims
- 4643US2005261343A1Anthranilamides and their use as pharmaceutical agentsKRUEGER MARTIN·Filed 2005·Application pending·0 cites
- 4743US2006014747A1Ortho-substituted anthranilic acid amides and their use as pharmaceutical agentsKRUEGER MARTIN·Filed 2005·Application pending·0 cites
- 4842US4721729ANovel carbacyclins, process for the preparation thereof, and their use as medicinal agentsSCHERING AG·Filed 1985·Granted Jan 26, 1988·3 cites·16 claims
- 4940US2004254185A1Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3Filed 2002·Application pending·0 cites
- 5038US7071344B1Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicamentsSCHERING AG·Filed 1998·Granted Jul 4, 2006·2 cites·29 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martin Haberey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →